These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 3102381)
1. Activation of murine macrophages and a bovine monocyte cell line by bovine lymphokines to kill the intracellular pathogens Eimeria bovis and Toxoplasma gondii. Hughes HP; Speer CA; Kyle JE; Dubey JP Infect Immun; 1987 Mar; 55(3):784-91. PubMed ID: 3102381 [TBL] [Abstract][Full Text] [Related]
2. Lymphokine-induced inhibition of growth of Eimeria bovis and Eimeria papillata (Apicomplexa) in cultured bovine monocytes. Speer CA; Reduker DW; Burgess DE; Whitmire WM; Splitter GA Infect Immun; 1985 Nov; 50(2):566-71. PubMed ID: 3876996 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Eimeria bovis and Toxoplasma gondii to oxygen intermediates and a new mathematical model for parasite killing. Hughes HP; Boik RJ; Gerhardt SA; Speer CA J Parasitol; 1989 Aug; 75(4):489-97. PubMed ID: 2760759 [TBL] [Abstract][Full Text] [Related]
4. Activation of neonatal and adult human macrophages by alpha, beta, and gamma interferons. Wilson CB; Westall J Infect Immun; 1985 Aug; 49(2):351-6. PubMed ID: 3926648 [TBL] [Abstract][Full Text] [Related]
5. Cellular defenses against Toxoplasma gondii in newborns. Wilson CB; Haas JE J Clin Invest; 1984 Jun; 73(6):1606-16. PubMed ID: 6327765 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli. Fischer HG; Opel B; Reske K; Reske-Kunz AB Eur J Immunol; 1988 Aug; 18(8):1151-8. PubMed ID: 3138135 [TBL] [Abstract][Full Text] [Related]
7. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular reducing thiols. Frosch S; Bonifas U; Eck HP; Bockstette M; Droege W; RĂ¼de E; Reske-Kunz AB Eur J Immunol; 1993 Jul; 23(7):1430-4. PubMed ID: 8325319 [TBL] [Abstract][Full Text] [Related]
8. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Newman SL; Gootee L Infect Immun; 1992 Nov; 60(11):4593-7. PubMed ID: 1398972 [TBL] [Abstract][Full Text] [Related]
9. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929 [TBL] [Abstract][Full Text] [Related]
10. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. Murray HW; Spitalny GL; Nathan CF J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of interferon-gamma activated ovine umbilical vein endothelial cells on the intracellular replication of Toxoplasma gondii. Dimier IH; Bout DT Vet Res; 1996; 27(4-5):527-34. PubMed ID: 8822620 [TBL] [Abstract][Full Text] [Related]
13. CD154 activates macrophage antimicrobial activity in the absence of IFN-gamma through a TNF-alpha-dependent mechanism. Andrade RM; Wessendarp M; Subauste CS J Immunol; 2003 Dec; 171(12):6750-6. PubMed ID: 14662879 [TBL] [Abstract][Full Text] [Related]
14. Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens. Black CM; Bermudez LE; Young LS; Remington JS J Exp Med; 1990 Sep; 172(3):977-80. PubMed ID: 2117640 [TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. Fischer HG; Frosch S; Reske K; Reske-Kunz AB J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506 [TBL] [Abstract][Full Text] [Related]
16. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2). Hamann U; Krammer PH Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924 [TBL] [Abstract][Full Text] [Related]
17. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor. Falk LA; Wahl LM; Vogel SN J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601 [TBL] [Abstract][Full Text] [Related]
18. Contribution of immune interferon (IFN-gamma) in lymphokine-induced anti-toxoplasma activity: studies with recombinant murine IFN-gamma. Sethi KK; Omata Y; Brandis H Immunobiology; 1985 Nov; 170(4):270-83. PubMed ID: 3936779 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage and macrophage colony-stimulating factors activate intramacrophage killing of Leishmania mexicana amazonensis. Ho JL; Reed SG; Wick EA; Giordano M J Infect Dis; 1990 Jul; 162(1):224-30. PubMed ID: 2113077 [TBL] [Abstract][Full Text] [Related]
20. Killing of schistosomula of Schistosoma mansoni by macrophages: induction by T-cell clone-derived lymphokines and interferon-gamma. Kubelka CF; Ruppel A; Krammer PH; Gemsa D Parasitology; 1986 Apr; 92 ( Pt 2)():325-36. PubMed ID: 3086820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]